Ikena Oncology Inc (IKNA)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: IKNA Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value	Details
2022-01-12	2022-01-11	PS Planned sale	Zhang Xiaoyan Michelle Chief Scientific Officer Officer	964 -2.1% 12.00 11,568 USD	964 -2.1%	12.00	11,568 USD
2022-01-12	2022-01-10	PS Planned sale	Zhang Xiaoyan Michelle Chief Scientific Officer Officer	36 -0.1% 12.00 432 USD	36 -0.1%	12.00	432 USD
2021-12-14	2021-12-14	S Sale	FORMELA JEAN FRANCOIS Non-Executive Director	5,959 -0.5% 14.00 83,426 USD	5,959 -0.5%	14.00	83,426 USD
2021-12-14	2021-12-14	S Sale	Atlas Venture Fund XI, L.P. Large shareholder	5,959 -0.5% 14.00 83,426 USD	5,959 -0.5%	14.00	83,426 USD
2021-12-14	2021-12-13	S Sale	FORMELA JEAN FRANCOIS Non-Executive Director	8,330 -0.7% 14.64 121,951 USD	8,330 -0.7%	14.64	121,951 USD
2021-12-14	2021-12-13	S Sale	Atlas Venture Fund XI, L.P. Large shareholder	8,330 -0.7% 14.64 121,951 USD	8,330 -0.7%	14.64	121,951 USD
2021-12-14	2021-12-10	S Sale	Zhang Xiaoyan Michelle Chief Scientific Officer Officer	1,000 -2.2% 14.76 14,760 USD	1,000 -2.2%	14.76	14,760 USD
2021-12-14	2021-12-10	S Sale	FORMELA JEAN FRANCOIS Non-Executive Director	11,989 -0.9% 15.03 180,195 USD	11,989 -0.9%	15.03	180,195 USD
2021-12-14	2021-12-10	S Sale	Atlas Venture Fund XI, L.P. Large shareholder	11,989 -0.9% 15.03 180,195 USD	11,989 -0.9%	15.03	180,195 USD
2021-12-14	2021-03-30	B Purchase	FORMELA JEAN FRANCOIS Non-Executive Director	125,000 +16.7% 16.00 2,000,000 USD	125,000 +16.7%	16.00	2,000,000 USD
2021-12-14	2021-03-30	B Purchase	Atlas Venture Fund XI, L.P. Large shareholder	125,000 +16.7% 16.00 2,000,000 USD	125,000 +16.7%	16.00	2,000,000 USD
2021-04-01	2021-03-30	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director	48,400 +70.2% 16.00 774,400 USD	48,400 +70.2%	16.00	774,400 USD
2021-04-01	2021-03-30	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director	375,000 +20.6% 16.00 6,000,000 USD	375,000 +20.6%	16.00	6,000,000 USD
2021-04-01	2021-03-30	B Purchase	Bonita David P Non-Executive Director	48,400 +70.2% 16.00 774,400 USD	48,400 +70.2%	16.00	774,400 USD
2021-04-01	2021-03-30	B Purchase	Bonita David P Non-Executive Director	375,000 +20.6% 16.00 6,000,000 USD	375,000 +20.6%	16.00	6,000,000 USD